Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V

Blood Cells, Molecules, and Diseases

Volumn 40, Issue 3, 2008, Pages 433-443

  Kang, Moonkyu ^a   Wilson, La'Tisha ^b   Kermode, John C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b TOUGALOO COLLEGE   (United States)

Author keywords

Glycoprotein Ib IX V; Platelet; Protein conformation; Thrombosis; Trypsin digestion; von Willebrand factor

Indexed keywords

ANTIBIOTIC AGENT; GLYCOPROTEIN IB; GLYCOPROTEIN IB IX V COMPLEX; HEPARIN; RISTOCETIN; TRYPSIN; UNCLASSIFIED DRUG; VANCOMYCIN; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION;

FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN CONFORMATION; RISTOCETIN; TRYPSIN; VANCOMYCIN; VON WILLEBRAND FACTOR;

EID: 41949088719     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.09.004     Document Type: Article

References (58)

1. Girma J.-P., Meyer D., Verweij C.L., et al. Structure-function relationship of human von Willebrand factor. Blood 70 (1987) 605-611
2. Ruggeri Z.M. von Willebrand factor. J. Clin. Invest. 99 (1997) 559-564
3. Andrews R.K., and Berndt M.C. Platelet physiology and thrombosis. Thromb. Res. 114 (2004) 447-453
4. Moake J.L., Turner N.A., Stathopoulos N.A., et al. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71 (1988) 1366-1374
5. Fujimura Y., Titani K., Holland L.Z., et al. von Willebrand factor: a reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J. Biol. Chem. 261 (1986) 381-385
6. Ginsburg D., and Sadler J.E. von Willebrand disease: a data base of point mutations, insertions and deletions. Thromb. Haemost. 69 (1993) 177-184
7. Castaman G., Federici A.B., Rodeghiero F., and Mannucci P.M. von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 88 (2003) 94-108
8. Randi A.M., Rabinowitz I., Mancuso D.J., et al. Molecular basis of von Willebrand disease type IIB: candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences. J. Clin. Invest. 87 (1991) 1220-1226
9. Rabinowitz I., Tuley E.A., Mancuso D.J., et al. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9846-9849
10. Emsley J., Cruz M.A., Handin R.I., and Liddington R. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib. J. Biol. Chem. 273 (1998) 10396-10401
11. Celikel R., Varughese K.I., Madhusudan, et al. Crystal structure of von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat. Struct. Biol. 5 (1998) 189-194
12. Celikel R., Ruggeri Z.M., and Varughese K.I. von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nat. Struct. Biol. 7 (2000) 881-884
13. Huizinga E.G., Tsuji S., Romijn R.A.P., et al. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 297 (2002) 1176-1179
14. Dumas J.J., Kumar R., McDonagh T., et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J. Biol. Chem. 279 (2004) 23327-23334
15. Hulstein J.J.J., de Groot P.G., Silence K., et al. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 106 (2005) 3035-3042
16. Kao K.-J., Pizzo S.V., and McKee P.A. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets. J. Clin. Invest. 63 (1979) 656-664
17. Ruggeri Z.M., De Marco L., Gatti L., et al. Platelets have more than one binding site for von Willebrand factor. J. Clin. Invest. 72 (1983) 1-12
18. Ajzenberg N., Ribba A.-S., Rastegar-Lari G., et al. Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation. Blood 95 (2000) 3796-3803
19. Dong J.-F., Berndt M.C., Schade A., et al. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood 97 (2001) 162-168
20. 3 analog KH1060. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10685-10690
21. Hubbard S.J. The structural aspects of limited proteolysis of native proteins. Biochim. Biophys. Acta 1382 (1998) 191-206
22. Fontana A., de Laureto P.P., Spolaore B., et al. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 51 (2004) 299-321
23. Kermode J.C., Zheng Q., and Milner E.P. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 94 (1999) 199-207
24. Furlan M., Robles R., Solenthaler M., et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89 (1997) 3097-3103
25. Soejima K., Matsumoto M., Kokame K., et al. ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood 102 (2003) 3232-3237
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Erlanger B.F., Kokowsky N., and Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch. Biochem. Biophys. 95 (1961) 271-278
28. Sobel M., McNeill P.M., Carlson P.L., et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J. Clin. Invest. 87 (1991) 1787-1793
29. Milner E.P., Zheng Q., and Kermode J.C. Ristocetin-mediated interaction of human von Willebrand factor with platelet glycoprotein Ib evokes a transient calcium signal: observations with Fura-PE3. J. Lab. Clin. Med. 131 (1998) 49-62
30. Scott J.P., Montgomery R.R., and Retzinger G.S. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets. J. Biol. Chem. 266 (1991) 8149-8155
31. Moake J.L., Cimo P.L., Peterson D.M., et al. Inhibition of ristocetin-induced platelet agglutination by vancomycin. Blood 50 (1977) 397-406
32. Moake J.L., Olson J.D., Troll J.H., et al. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination. J. Lab. Clin. Med. 96 (1980) 168-184
33. Fujimura Y., Titani K., Holland L.Z., et al. A heparin-binding domain of human von Willebrand factor: characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J. Biol. Chem. 262 (1987) 1734-1739
34. Sobel M., Soler D.F., Kermode J.C., and Harris R.B. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J. Biol. Chem. 267 (1992) 8857-8862
35. 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J. Biol. Chem. 267 (1992) 11300-11306
36. Andrews R.K., Booth W.J., Gorman J.J., et al. Purification of botrocetin from Bothrops jararaca venom: analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 28 (1989) 8317-8326
37. Fukuda K., Doggett T.A., Bankston L.A., et al. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure 10 (2002) 943-950
38. Fukuda K., Doggett T., Laurenzi I.J., et al. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation. Nat. Struct. Mol. Biol. 12 (2005) 152-159
39. Berndt M.C., Ward C.M., Booth W.J., et al. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor: mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 31 (1992) 11144-11151
40. Miyata S., and Ruggeri Z.M. Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibα under flow. J. Biol. Chem. 274 (1999) 6586-6593
41. Ulrichts H., Udvardy M., Lenting P.J., et al. Shielding of the A1 domain by the D′D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J. Biol. Chem. 281 (2006) 4699-4707
42. Titani K., Kumar S., Takio K., et al. Amino acid sequence of human von Willebrand factor. Biochemistry 25 (1986) 3171-3184
43. Schulte am Esch J., Robson S.C., Knoefel W.T., et al. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Br. J. Haematol. 128 (2005) 82-90
44. Fowler W.E., Fretto L.J., Hamilton K.K., et al. Substructure of human von Willebrand factor. J. Clin. Invest. 76 (1985) 1491-1500
45. Slayter H., Loscalzo J., Bockenstedt P., and Handin R.I. Native conformation of human von Willebrand protein: analysis by electron microscopy and quasi-elastic light scattering. J. Biol. Chem. 260 (1985) 8559-8563
46. Siedlecki C.A., Lestini B.J., Kottke-Marchant K., et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88 (1996) 2939-2950
47. Loscalzo J., Fisch M., and Handin R.I. Solution studies of the quaternary structure and assembly of human von Willebrand factor. Biochemistry 24 (1985) 4468-4475
48. Shankaran H., Alexandridis P., and Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood 101 (2003) 2637-2645
49. Singh I., Shankaran H., Beauharnois M.E., et al. Solution structure of human von Willebrand factor studied using small angle neutron scattering. J. Biol. Chem. 281 (2006) 38266-38275
50. Furlan M., Robles R., and Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
51. Tsai H.-M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87 (1996) 4235-4244
52. Dong J.-F., Moake J., Nolasco L., et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 100 (2002) 4033-4039
53. Nishio K., Anderson P.J., Zheng X.L., and Sadler J.E. Binding of platelet glycoprotein Ibα to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10578-10583
54. Bowen D.J. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J. Thromb. Haemost. 1 (2003) 33-40
55. Sixma J.J., Sakariassen K.S., Stel H.V., et al. Functional domains on von Willebrand factor: recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J. Clin. Invest. 74 (1984) 736-744
56. Berkowitz S.D., and Federici A.B. Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage. Blood 72 (1988) 1790-1796
57. Katayama M., Hirai S., Kato I., and Titani K. Immunoenzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites. Clin. Biochem. 27 (1994) 123-131
58. Marti T., Rösselet S.J., Titani K., and Walsh K.A. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 26 (1987) 8099-8109